Adipokine Profile in Patients with Type 2 Diabetes Depends on Degree of Obesity

Background The fast pace of life, promoting fast food consumption and low physical activity, has resulted in obesity and/or diabetes as being serious social problems. The aim of the present study was to evaluate concentrations of selected adipokines (leptin, adiponectin, resistin, and visfatin) and to assess the leptin/adiponectin ratio in plasma of type 2 diabetes (T2D) patients in relation to degree of obesity. Material/Methods The study comprised 92 T2D subjects divided into 4 groups according to BMI value – I (normal body weight), II (overweight), III (obesity), and IV (severe obesity) – and 20 healthy volunteers (control group). Each group was divided into male and female subgroups. Plasma concentrations of adipokines were determined by enzyme-linked immunosorbent assay. Results In women, leptin concentration was significantly higher in group IV, whereas in men it was higher in groups III and IV than in the control group and groups I and II. Irrespective of sex, a significant decrease in adiponectin level was observed in group III vs. control. There was no significant difference in resistin levels. In women visfatin was markedly enhanced in group III, whereas in men in groups II, III and IV vs. control. Leptin/adiponectin ratio was increased in groups III and IV vs. control in women, whereas in men vs. both control and group I. Conclusions The obese type 2 diabetic patients presented a disturbed adipokine profile, which seems to be an important link between obesity and T2D. The future studies concerning the question if regulating of adipokines’ concentrations could be a promising approach for managing metabolic disorders seem to be well-grounded.

[1]  C. Ionescu-Tirgoviste,et al.  Markers of Oxidative Stress and Antioxidant Defense in Romanian Patients with Type 2 Diabetes Mellitus and Obesity , 2017, Molecules.

[2]  G. Dong,et al.  [Effect of laparoscopic sleeve gatrectomy on type 2 diabetes mellitus in obese patients with body mass index less than 40 kg/m2]. , 2017, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.

[3]  Mona Hmoud Al Sheikh,et al.  The Determinants of Leptin Levels in Diabetic and Nondiabetic Saudi Males , 2017, International journal of endocrinology.

[4]  J. Mejía-Aranguré,et al.  Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country , 2017, BMC Cancer.

[5]  M. Qadir,et al.  lep Expression and Its Role in Obesity and Type-2 Diabetes. , 2017, Critical reviews in eukaryotic gene expression.

[6]  R. Susilowati,et al.  Sexual dimorphism in interleukin 17A and adipocytokines and their association with insulin resistance among obese adolescents in Yogyakarta, Indonesia. , 2016, Asia Pacific journal of clinical nutrition.

[7]  E. Sijbrands,et al.  Levels of the Soluble Ldl Receptor-relative Lr11 Decrease in Overweight 1 Individuals with Type 2 Diabetes upon Diet-induced Weight Loss 2 3 4 , 2022 .

[8]  Guifen Niu,et al.  Associations of A-FABP with Anthropometric and Metabolic Indices and Inflammatory Cytokines in Obese Patients with Newly Diagnosed Type 2 Diabetes , 2016, BioMed research international.

[9]  S. Wiegand,et al.  Leptin but not adiponectin is related to type 2 diabetes mellitus in obese adolescents , 2016, Pediatric diabetes.

[10]  J. Bienertová-Vašků,et al.  The role of visfatin (PBEF/Nampt) in pregnancy complications. , 2015, Journal of reproductive immunology.

[11]  M. Connelly,et al.  GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status. , 2015, Clinical biochemistry.

[12]  A. Sriwijitkamol,et al.  Cardiometabolic risk in Thai adults with type 2 diabetes mellitus: obese versus non-obese. , 2015, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[13]  R. Urso,et al.  Clinical and biochemical effects of a 3-week program of diet combined with spa therapy in obese and diabetic patients: a pilot open study , 2015, International Journal of Biometeorology.

[14]  M. Al-Habori,et al.  Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus , 2014, Diabetology & Metabolic Syndrome.

[15]  A. Santos-Silva,et al.  Adiponectin, Leptin, and Chemerin in Elderly Patients with Type 2 Diabetes Mellitus: A Close Linkage with Obesity and Length of the Disease , 2014, BioMed research international.

[16]  X. Gu,et al.  Serum leptin levels in obese women with and without type 2 diabetes mellitus. , 2014, Minerva endocrinologica.

[17]  K. Lalić,et al.  Relationship between Obesity, Adipocytokines and Inflammatory Markers in Type 2 Diabetes: Relevance for Cardiovascular Risk Prevention , 2014, International journal of environmental research and public health.

[18]  M. Ghaffari,et al.  Additional Effect of Diabetes Mellitus Type 2 on the Risk of Coronary Artery Disease: Role of Serum Adiponectin , 2014, Iranian Red Crescent Medical Journal.

[19]  R. Ahima,et al.  Resistin in Rodents and Humans , 2013, Diabetes & metabolism journal.

[20]  M. Banach,et al.  Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease , 2013, Medical science monitor : international medical journal of experimental and clinical research.

[21]  P. Ismail,et al.  Analysis of Gln223Agr Polymorphism of Leptin Receptor Gene in Type II Diabetic Mellitus Subjects among Malaysians , 2013, International journal of molecular sciences.

[22]  Vandana Saini,et al.  Role of leptin and adiponectin in insulin resistance. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[23]  G. Brimas,et al.  Comparison of changes in blood glucose, insulin resistance indices, and adipokine levels in diabetic and nondiabetic subjects with morbid obesity after laparoscopic adjustable gastric banding. , 2013, Medicina.

[24]  A. Santos-Silva,et al.  Adipokines, Oxidized Low-Density Lipoprotein, and C-Reactive Protein Levels in Lean, Overweight, and Obese Portuguese Patients with Type 2 Diabetes , 2013, ISRN obesity.

[25]  N. Zarghami,et al.  Serum Leptin Level Is Reduced in Non-Obese Subjects with Type 2 Diabetes , 2012, International journal of endocrinology and metabolism.

[26]  K. Vivek,et al.  Evaluation Of Serum Bio Markers [Leptin, Adiponectin, Crp, Oxidised- Ldl] And Lipid Parameter In Obese With Type-2 Diabetes Mellitus: Risk To CVD , 2013 .

[27]  Debojyoti Bhattacharjee,et al.  Association of obesity and leptin with insulin resistance in type 2 diabetes mellitus in Indian population. , 2013, Indian journal of physiology and pharmacology.

[28]  D. Soliman,et al.  Serum visfatin, resistin and IL-18 in A group of Egyptian obese diabetic and non diabetic individuals. , 2013, The Egyptian journal of immunology.

[29]  A. Shehzad,et al.  Serum Adipokines Metabolic Function and Immunological Correlations in Treated Type 2 Diabetes mellitus and Obese Subjects , 2013 .

[30]  A. Kazmi,et al.  Association of leptin with type 2 diabetes in non-obese subjects. , 2012, Journal of Ayub Medical College, Abbottabad : JAMC.

[31]  M. Hosseinzadeh‐Attar,et al.  Elevated serum visfatin levels in patients with acute myocardial infarction. , 2012, Archives of Iranian medicine.

[32]  Chia-Jen Tsai,et al.  Acute blood glucose fluctuations can decrease blood glutathione and adiponectin levels in patients with type 2 diabetes. , 2012, Diabetes research and clinical practice.

[33]  D. Mikhailidis,et al.  Plasma visfatin and retinol binding protein-4 levels in patients with type 2 diabetes mellitus and their relationship to adiposity and fatty liver. , 2011, Clinical biochemistry.

[34]  A. Vaag,et al.  Impact of Physical Inactivity on Adipose Tissue Low-Grade Inflammation in First-Degree Relatives of Type 2 Diabetic Patients , 2011, Diabetes Care.

[35]  Yu-Hung Chang,et al.  Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review , 2011, Diabetes/metabolism research and reviews.

[36]  Lei Qian,et al.  Visfatin inhibits apoptosis of pancreatic β-cell line, MIN6, via the mitogen-activated protein kinase/phosphoinositide 3-kinase pathway. , 2011, Journal of molecular endocrinology.

[37]  R. Meeusen,et al.  © The Author(s) 2010. This article is published with open access at Springerlink.com Communicated by Jacques Poortmans. , 2010 .

[38]  N. Zarghami,et al.  Serum Resistin Concentration in Obese Diabetic patients: Any Possible Relation to Insulin Resistance Indices? , 2008 .

[39]  R. Ahima,et al.  Adipokines in obesity. , 2008, Frontiers of hormone research.

[40]  J. Bełtowski Apelin and visfatin: unique "beneficial" adipokines upregulated in obesity? , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[41]  S. Yaturu,et al.  Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes. , 2006, Cytokine.